1,312 Shares in Cencora, Inc. (NYSE:COR) Bought by Heritage Oak Wealth Advisors LLC

Heritage Oak Wealth Advisors LLC bought a new position in shares of Cencora, Inc. (NYSE:COR - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 1,312 shares of the company's stock, valued at approximately $295,000.

Other hedge funds have also added to or reduced their stakes in the company. Swedbank AB grew its stake in shares of Cencora by 2.3% in the third quarter. Swedbank AB now owns 1,394,449 shares of the company's stock valued at $313,863,000 after buying an additional 31,104 shares in the last quarter. Allworth Financial LP lifted its stake in Cencora by 22.8% in the third quarter. Allworth Financial LP now owns 1,672 shares of the company's stock valued at $376,000 after acquiring an additional 310 shares during the last quarter. Louisiana State Employees Retirement System grew its position in shares of Cencora by 4.3% in the 3rd quarter. Louisiana State Employees Retirement System now owns 9,800 shares of the company's stock valued at $2,206,000 after acquiring an additional 400 shares during the period. Arkadios Wealth Advisors increased its stake in shares of Cencora by 3.5% during the 3rd quarter. Arkadios Wealth Advisors now owns 2,221 shares of the company's stock worth $500,000 after purchasing an additional 76 shares during the last quarter. Finally, J.W. Cole Advisors Inc. raised its holdings in shares of Cencora by 1.3% in the 3rd quarter. J.W. Cole Advisors Inc. now owns 3,669 shares of the company's stock valued at $826,000 after purchasing an additional 48 shares during the period. Institutional investors own 97.52% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on COR. JPMorgan Chase & Co. boosted their price target on Cencora from $289.00 to $301.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. Wells Fargo & Company increased their price target on Cencora from $237.00 to $251.00 and gave the company an "equal weight" rating in a research note on Wednesday, January 29th. Mizuho initiated coverage on shares of Cencora in a research report on Wednesday, December 4th. They set an "outperform" rating and a $280.00 price objective for the company. UBS Group upped their price objective on shares of Cencora from $275.00 to $285.00 and gave the company a "buy" rating in a report on Thursday, November 7th. Finally, Barclays raised their target price on shares of Cencora from $263.00 to $290.00 and gave the stock an "overweight" rating in a research note on Thursday, November 7th. Two analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $277.90.

Cencora Stock Performance

Shares of NYSE:COR traded up $1.68 on Monday, reaching $255.22. 1,367,959 shares of the company's stock were exchanged, compared to its average volume of 1,500,152. The company has a current ratio of 0.92, a quick ratio of 0.54 and a debt-to-equity ratio of 16.40. Cencora, Inc. has a twelve month low of $214.77 and a twelve month high of $262.26. The company has a fifty day moving average of $241.71 and a 200-day moving average of $237.85. The company has a market capitalization of $49.49 billion, a price-to-earnings ratio of 36.30, a PEG ratio of 1.31 and a beta of 0.49.

Cencora (NYSE:COR - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $3.73 EPS for the quarter, topping analysts' consensus estimates of $3.50 by $0.23. Cencora had a return on equity of 328.62% and a net margin of 0.46%. On average, research analysts predict that Cencora, Inc. will post 15.37 EPS for the current fiscal year.

Cencora Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Friday, February 14th will be paid a dividend of $0.55 per share. The ex-dividend date is Friday, February 14th. This represents a $2.20 dividend on an annualized basis and a yield of 0.86%. Cencora's payout ratio is 31.29%.

Insider Buying and Selling at Cencora

In other Cencora news, EVP Silvana Battaglia sold 5,000 shares of the firm's stock in a transaction on Friday, February 21st. The stock was sold at an average price of $242.24, for a total value of $1,211,200.00. Following the sale, the executive vice president now owns 15,374 shares of the company's stock, valued at approximately $3,724,197.76. This trade represents a 24.54 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 10.80% of the company's stock.

About Cencora

Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.